Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Pharmacokinetics Année : 2023

Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach

Résumé

Chronic kidney disease (CKD) may alter drug renal elimination but is also known for interacting with hepatic metabolism via multiple uremic components. However, few global models, considering the five major cytochromes, have been published, and none specifically address the decrease in cytochrome P450 (CYP450) activity. The aim of our study was to estimate the possibility of quantifying residual cytochrome activity as a function of filtration rate, according to the data available in the literature.

Domaines

Pharmacologie
Fichier non déposé

Dates et versions

hal-04626090 , version 1 (26-06-2024)

Identifiants

Citer

Vianney Tuloup, Sylvain Goutelle, Michel Tod, Laurent Bourguignon. Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach. Clinical Pharmacokinetics, 2023, 62 (2), pp.307-319. ⟨10.1007/s40262-022-01205-3⟩. ⟨hal-04626090⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More